ENDOMETRIOSIS - THE RECOMMENDED DAILY DOSE OF NASAREL IS 400 Β΅G. THIS IS ACHIEVED BY ONE SPRAY (200 Β΅G) INTO ONE NOSTRIL IN THE MORNING AND ONE SPRAY INTO THE OTHER NOSTRIL IN THE EVENING. TREATMENT SHOULD BE STARTED BETWEEN DAYS 2 AND 4 OF THE MENSTRUAL CYCLE. THE RECOMMENDED DURATION OF ADMINISTRATION IS SIX MONTHS. SNEEZING DURING OR IMMEDIATELY AFTER DOSING WITH NASAREL SHOULD BE AVOIDED, IF POSSIBLE, SINCE THIS MAY IMPAIR DRUG ABSORPTION.
PITUITARY DESENSITISATION BEFORE INDUCTION OF OVULATION BY GONADOTROPHINS FOR IN VITRO FERTILISATION (UNDER SPECIALIST SUPERVISION), 400 MICROGRAMS (ONE SPRAY IN EACH NOSTRIL) TWICE DAILY STARTING IN EARLY FOLLICULAR PHASE (DAY 2) OR, AFTER EXCLUSION OF PREGNANCY, IN MIDLUTEAL PHASE (DAY 21) AND CONTINUED UNTIL DOWN-REGULATION ACHIEVED (USUALLY WITHIN 4 WEEKS) THEN MAINTAINED (USUALLY FOR 8 - 12 DAYS) DURING GONADOTROPHIN ADMINISTRATION (STOPPING GONADOTROPHIN AND NAFARELIN ON ADMINISTRATION OF CHORIONIC GONADOTROPHIN AT FOLLICULAR MATURITY); DISCONTINUE IF DOWN-REGULATION NOT ACHIEVED WITHIN 12 WEEKS
COUNSELLING AVOID USE OF NASAL DECONGESTANTS BEFORE AND FOR AT LEAST 30 MINUTES AFTER TREATMENT; REPEAT DOSE IF SNEEZING OCCURS DURING OR IMMEDIATELY AFTER ADMINISTRATION